Abstract:Background: The level of carcinoembryonic antigen (CEA) in the diagnosis of early gastric cancer (EGC) seems obscure. This study is aimed to assess whether a high level of CEA is associated with the inferior prognosis for EGC. Methods: About 203 EGC patients, who received endoscopic mucosal resection or submucosal dissection or radical gastrectomy, were reviewed retrospectively. All the EGC cases were evaluated based on their clinicopathological features and surgical outcomes. The X-tile program was used to calculate the optimal cut-off points for the CEA using minimum P-value from log-rank divided by 2 statistics. In the analysis of the overall cumulative probability of survival, the Kaplan-Meier method was employed. Their differences were evaluated through the log-rank test. The Cox multiple factors analysis was carried out using the logistic regression method. Results: The X-tile plots cut-off points for CEA were 15.54 ng/ml in EGC patients. They were classified as CEA-low and CEA-high groups. The percentage of the vessel carcinoma embolus was higher in CEA-high groups compared to their CEA-low counterparts (20% vs. 16.29%, P = 0.000). The five-year overall survival rate (OS) of the patients under CEA-high group was markedly inferior compared to the CEA-low group (68.95% vs. 99.42%, P < 0.05). The multivariate survival analysis showed that CEA (OR = 1.674), N stage (OR = 2.436) were significant prognostic factors for EGC (all P < 0.05). In the CEA-low subgroup, not signally risk factors were found (all P > 0.05), while N stage (OR = 2.632) was an independent risk factor in the CEA-high group by multivariate analysis (P < 0.05). Conclusion: The CEA, categorized by the cut-off points of 15.44 ng/ml could develop the best prognostic discriminatory ability and predictive accuracy for the EGC patients. It could be a reliable prognostic factor when combined with tumor node metastasis (TNM) evaluation system.

Prokaryotic expression of anti-carcinoembryonic single-chain variable fragment and its value in detection of gastric carcinoma cells

Cmar_a_246566 2767..2775

Clinical Value of Serum CEA,CAl9-9 and CA125 Measurement in Gastric Cancer

Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer

Serum Level and Expression of CEACAM6 in Gastric Cancer Tissue and Its Clinical Significance

Molecular Detection of Disseminated Tumor Cells in the Peripheral Blood of Patients with Gastric Cancer: Evaluation of Their Prognostic Significance

Study of Differential Polymerase Chain Reaction of C-erbB-2 Oncogene Amplification in Gastric Cancer

The Diagnostic Value of Chemokine CC-motif Ligand 18(CCL18) for Gastric Cancer

Clinical significance of CEA and CK20 expression in exfoliated cells by fiberoptic bronchoscopy brushing

Expression and significance of VEGF-C and CEACAM-1 in gastroenteric carcinoma tissues by fluorescence quantitation polymerase chain reaction

High Expression Of Serum Carcinoembryonic Antigen (Cea) Associated With Poor Prognosis In Early Gastric Cancer: A Single-Center Retrospective Study

Characterization of Monoclonal Antibody CL58 Against Carcinoembryonic Antigen (CEA) and Study of Its Biodistribution

Detection and application of cell-free nucleic acid biomarkers for diagnosis of gastric cancer

Initial Evaluation of 99m Tc-labeled Anti-Carcinoembryonic Antigen Single-Chain Fragment Variable for Micro-Single-photon Emission Computed Tomography Imaging in Mice with Colorectal Cancer.

Application of the Combined Detection of Pepsinogen, Gastrin-17,CEA and CA19-9 in the Diagnosis of Gastric Cancer

Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer

Screening and identification of CD44v9 specific peptide ligand for gastric cancer detection

Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models

Evaluation of the value of combined detection of tumor markers CA724, carcinoembryonic antigen, CA242, and CA19-9 in gastric cancer

A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay)

Initial evaluation of 99m Tc‐labeled anti‐CEA scFv for micro‐SPECT imaging in mice with colorectal cancer